Stock Report: PharMerica Corp. (PMC) Report Updated: May 13, 2013 | Print This Page
Report Features:
Stock Analysis
Rating: Monthly View
| A | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B | ||||||||||||
| C | ||||||||||||
| D | ||||||||||||
| F | ||||||||||||
Rating: Weekly View
| This Week: | C |
|---|---|
| Last Week: | C |
| Two Weeks Ago: | C |

Company Profile
Pharmerica Corporation operates as an institutional pharmacy services company in the United States. It offers services to healthcare facilities and provides management pharmacy services to hospitals. The company purchases, repackages, and dispenses prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers such medication to healthcare facilities for administration to individual patients and residents. It also provides consultant pharmacist services for customers to comply with the federal and state regulations applicable to nursing homes; and medical records services. In addition, the company offers various ancillary services, such as infusion therapy products and services; and hospital pharmacy management services, including hospital pharmacy operations, regulatory and financial management services, and clinical pharmacy programs to various hospitals. PharMerica Corporation operates approximately 95 institutional pharmacies in 44 states and provides pharmacy management services to 91 hospitals. Its customers primarily include institutional healthcare providers, such as skilled nursing facilities, nursing centers, assisted living facilities, hospitals, and other long-term alternative care settings. The company is headquartered in Louisville, Kentucky.
Recent News: PharMerica Corp.
| 2012-10-09 00:00:00 | Amendment to the SC 13G filing - Form SC 13G/A |
| 2012-10-05 12:37:00 | PharMerica Corporation to Broadcast Third Quarter 2012 Results Conference Call Live on the Internet |
| 2012-09-27 16:47:00 | PharMerica Corporation Names Mark Lindemoen Senior Vice President of Sales and Client Services |
| 2012-09-27 00:00:00 | Initial statement of beneficial ownership of securities - Form 3 |
| 2012-08-02 16:12:00 | PharMerica Reports Results for the Second Quarter of 2012 and Six Months Ended June 30, 2012 |
My Portfolios (View All)
Save your portfolio—or a few for that matter—and check up on your stocks 24/7! Log in here.
Louis Navellier's Portfolios
- Blue Chip GrowthTop blue chips
- Emerging GrowthTop small-caps
- Ultimate GrowthFastest-moving
- Platinum GrowthElite Model Portfolio



